IL6 and type 2 diabetes mellitus: Although the results reported in the literature on the association between IL-6 and T2D are contradictory [26,28,29], the absence of statistical differences in IL-6 and other inflammatory parameters could be related to the fact that most patients were treated with medications such as metformin, antihypertensive agents and lipid-lowering drugs, which have demonstrated a beneficial effect on inflammation [12-14].